420 with CNW — Commissioner Califf Admits FDA Hasn’t Done Much on CBD

While addressing a Congressional panel, FDA chief Dr. Robert Califf admitted that the agency he heads hasn’t been as fast as stakeholders may want as it handles matters of creating regulatory pathways for different products, including cannabidiol, extracted from hemp. This is despite the legalization at a federal level of hemp as well as its derivatives several years ago.

He admitted that while things look the same as they were when hemp was legalized back in 2018, his agency now has more data because it has been doing plenty of research. He added that most of the funds allocated to the FDA on matters of CBD regulation had gone to studying potential risks associated with the use of the different forms of CBD and application methods.

Califf told the subcommittee of the House Appropriations Committee that even if he was prepared to move ahead with finding ways to regulate CBD, it would be better if Congress gave the FDA additional powers on the matter beyond what it currently has. As a way of explaining what he meant, the commissioner observed that the current powers the FDA had in regulating foods on the one hand and drugs on the other hand are inadequate for this situation and something totally different (a new framework) would be required to get the needed regulations in place.

The FDA commissioner faced a barrage of questions from lawmakers on both sides of the political divide expressing their frustration about the agency’s inaction, which has resulted in widespread confusion among manufacturers and consumers.

Early this month, Rep. James Comer, a ranking GOP member of the House Oversight & Reform Committee, penned a letter to the chair of the committee requesting a sitting dedicated to holding the U.S. Food and Drug Administration responsible for its failure to formulate the necessary regulations so that the CBD sector can be overseen by this agency.

Subcommittee members also probed the commissioner about his agency’s view about kratom. He said kratom has some worrying side effects, which was why the FDA had tightened import controls on this “controversial tree.” The members, including Rep. Mark Pocan, responded to his answers by saying NIDA had a different perspective on kratom and that the FDA should see what NIDA had on this plant.

Commenting about the responses of the FDA commissioner during the Thursday hearing, several cannabis advocacy groups were cautiously optimistic that Califf would steer the agency appropriately on matters of regulating CBD. For example, the U.S. Hemp Roundtable took some encouragement from Califf’s tone, which signaled that he was personally unhappy that nothing had been done to regulate CBD since hemp had become federally legal.

The entire cannabis sector would likely benefit if there were federal regulations creating markets that entities such as American Cannabis Partners could serve from one coast to the other.

NOTE TO INVESTORS: The latest news and updates relating to American Cannabis Partners are available in the company’s newsroom at https://cnw.fm/ACP

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

Archives

Select A Month
  • November 2026
  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • January 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • September 2016
  • August 2016
  • July 2016
  • Official NewsWire Relationships

    Alternative Products Expo Benzinga Cannabis Capital Conference Cannabis Business Summit & Expo 2019 Cannabis Drinks Expo Cannabis World Congress & Business Exposition Cannexpo Marigold PR MjMicro Conference New England Cannabis Network O'Cannabiz Conference & Expo Tether BudTender Tether BudTender Appreciation Week

    CannabisNewsWire Currently Accepts

    Bitcoin

    Bitcoin

    Bitcoin Cash

    Bitcoin Cash

    Doge Coin

    Dogecoin

    Ethereum

    Ethereum

    Litecoin

    Litecoin

    USD Coin

    USD Coin

    Contact us: 512.354.7000